Amarin Corp Plcuk (AMRN) Interest Expenses (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Interest Expenses of $8.8 million for Q2 2026, down 27.47% year-over-year from $12.2 million in Q2 2025, and down 7.7% quarter-over-quarter from $9.6 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Interest Expenses (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Interest Expenses for 17 consecutive years, with $8.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest Expenses fell 27.47% year-over-year to $8.8 million; the TTM figure through Jun 2026 stood at $8.8 million (down 27.47% YoY), while the FY2025 annual figure was $173.8 million, down 7.32% from the prior year.
- Interest Expenses declined to $8.8 million in Q2 2026 per AMRN's latest filing, from $9.6 million in the prior quarter.
- Across five years, Interest Expenses topped out at $187.6 million in Q4 2024 and bottomed at $646000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $40.0 million across 5 years, with a median of $14.5 million in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses climbed 9.18% — and 2025, when it tumbled 99.66%.
- Amarin Corp Plc\Uk's Interest Expenses stood at $165.4 million in 2022, then gained by 3.88% to $171.8 million in 2023, then advanced by 9.18% to $187.6 million in 2024, then sank by 99.66% to $646000.0 in 2025, then surged by 1269.04% to $8.8 million in 2026.
- Business Quant data shows AMRN's Interest Expenses at $8.8 million in Q2 2026, $9.6 million in Q1 2026, and $646000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 462.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 435.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -244.19 Mn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.84 Mn |
| Jun 30, 2026 | 8.84 Mn |
| Mar 31, 2026 | 9.58 Mn |
| Mar 31, 2026 | 9.58 Mn |
| Dec 31, 2025 | 646,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Sep 30, 2025 | 11.41 Mn |
| Sep 30, 2025 | 11.41 Mn |
| Jun 30, 2025 | 12.19 Mn |
| Jun 30, 2025 | 12.19 Mn |
| Mar 31, 2025 | 13.27 Mn |
| Mar 31, 2025 | 13.27 Mn |
| Dec 31, 2024 | 187.56 Mn |
| Dec 31, 2024 | 187.56 Mn |
| Sep 30, 2024 | 13.48 Mn |
| Sep 30, 2024 | 13.48 Mn |
| Jun 30, 2024 | 13.20 Mn |
| Jun 30, 2024 | 13.20 Mn |
| Mar 31, 2024 | 13.87 Mn |
| Mar 31, 2024 | 13.87 Mn |